SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-16-000139
Filing Date
2016-03-31
Accepted
2016-03-31 16:36:27
Documents
3
Period of Report
2016-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kconsobmonthly201602201.htm 8-K 39347
2 EXHIBIT 99.1 ex991consobmonthly201602.htm EX-99.1 43028
3 ctilogoa04.jpg GRAPHIC 5054
  Complete submission text file 0000891293-16-000139.txt   90726
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 161543692
SIC: 2834 Pharmaceutical Preparations